Absci Corporation, a data-first generative AI drug creation company, announced a strategic collaboration with AMD to deploy AMD Instinct™ accelerators and ROCm™ software to power...
PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced an expansion of their partnership with Pfizer. The parties will launch...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target for Heart Failure to...